Govt takes 'Make in India' campaign to pharma sector

The recommendations by a Committee to accelerate the manufacturing of bulk drugs under ‘Make In India’ initiative, are set to be implemented soon for formulating a policy in this regard


The government has taken various measures to promote the ‘Make in India' initiative in pharmaceutical sector. In this direction, it had constituted a Committee under the chairmanship of secretary, Department of Health Research. This was stated by the union minister of chemicals and fertilizers, Mr Ananth Kumar in the Lok Sabha on April 21, 2015.

Mr Ananth Kumar added further, "The mandate of this Committee was to carefully study the whole issue of APIs of critical importance by identifying important APIs and then working out a package of interventions/concessions required to build domestic production capabilities and examine the cost implications."

The minister assured that the recommendations by the Committee are being examined for formulation of a policy for promotion of manufacturing of bulk drugs"

"The committee which has since submitted its recommendation has, inter-alia, recommended establishment of Mega Parks for APIs with common facilities such as common Effluent Treatments Plants (ETPs), Testing facilities, Captive Power Plants/assured power supply by state systems, Common Utilities/Services such as storage, testing laboratories, IPR management, designing etc., maintained by a separate Special Purpose Vehicles (SPV)," revealed Mr Kumar. 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email